Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 108984
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.108984
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.108984
Figure 5 Frequencies of programmed death-ligand 1 expression in immune cells according to marker determination methods.
A: Fre quencies of programmed death-ligand 1 (PD-L1) expression for all three markers and their combinations; B: Frequencies of programmed cell death protein 1 Ligand 1 (PDCD1 LG1) and PD-L1 (clone SP142) expression and their combination; C: Frequencies of PDCD1 LG1 and PD-L1 [polymerase chain reaction (PCR)] expression and their combination; D: Frequencies of PD-L1 (clone SP142) and PD-L1 (PCR) expression and their combination. PCR: Polymerase chain reaction; PDCD1 LG1: Programmed cell death protein 1 Ligand 1; PD-L1: Programmed death-ligand 1.
- Citation: Senchukova MA, Saidler NV, Zubareva EY, Prokofiev AB, Tagabilev DG. Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method. World J Exp Med 2025; 15(3): 108984
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/108984.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.108984